Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28
Frequently Asked Questions
What is Market Cap of Corbus Pharmaceuticals Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Corbus Pharmaceuticals Holdings Inc market cap is $121.2M.
What is the 52-week high for Corbus Pharmaceuticals Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Corbus Pharmaceuticals Holdings Inc 52 week high is $56.93 as of September 09, 2025.
What is the 52-week low for Corbus Pharmaceuticals Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Corbus Pharmaceuticals Holdings Inc 52 week low is $4.64 as of September 09, 2025.
What is Corbus Pharmaceuticals Holdings Inc stock price today?
Corbus Pharmaceuticals Holdings Inc stock price today is $9.53.
What was Corbus Pharmaceuticals Holdings Inc stock price yesterday?
Corbus Pharmaceuticals Holdings Inc stock price yesterday was $9.89.
What is the PE ratio of Corbus Pharmaceuticals Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Corbus Pharmaceuticals Holdings Inc’s P/E ratio is -2.08.
What is the Price-to-Book ratio of Corbus Pharmaceuticals Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Corbus Pharmaceuticals Holdings Inc P/B ratio is 1.0919.
What is the 50-day moving average of Corbus Pharmaceuticals Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Corbus Pharmaceuticals Holdings Inc 50-day moving average is $8.93.
How many employess does Corbus Pharmaceuticals Holdings Inc has?
Corbus Pharmaceuticals Holdings Inc has 28 employees.